Showing results (261-270 of 3,634) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|July 12, 2017
Predicting treatment resistance and relapse through circulating DNAEmma Beddowes, Stephen J Sammut, Meiling Gao, et al.
Breast (Edinburgh, Scotland)|April 18, 2018
All pure flat atypical atypia lesions of the breast diagnosed using percutaneous vacuum-assisted breast biopsy do not need surgical excisionLobna Ouldamer, Elodie Poisson, Flavie Arbion, et al.
Breast (Edinburgh, Scotland)|April 21, 2018
Validation of the CPS+EG and Neo-Bioscore staging systems after preoperative systemic therapy for breast cancer in a single center in ChinaLing Xu, Xuening Duan, Bin Zhou, et al.
Breast (Edinburgh, Scotland)|April 21, 2018
Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare settingR X Wong, F Y Wong, John Lim, et al.
Breast (Edinburgh, Scotland)|April 27, 2018
A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOPToshimi Takano, Junji Tsurutani, Masato Takahashi, et al.
Breast (Edinburgh, Scotland)|May 26, 2018
Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohortTal Sella, Einav Nili Gal Yam, Keren Levanon, et al.
Breast (Edinburgh, Scotland)|April 16, 2018
Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancerAnju Gangadharan, Themba Nyirenda, Kishan Patel, et al.
Breast (Edinburgh, Scotland)|April 16, 2018
Delay of adjuvant radiotherapy due to postoperative complications after oncoplastic breast conserving surgeryNadine S Hillberg, Marleen A J Meesters-Caberg, Jop Beugels, et al.
Breast (Edinburgh, Scotland)|August 30, 2016
Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypesTomoko Higuchi, Arisa Nishimukai, Hiromi Ozawa, et al.
Breast (Edinburgh, Scotland)|September 18, 2016
Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in FranceAline Hurtaud, Anne Donnadieu, Laurence Escalup, et al.
Pageof 364